Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ORTHODONTIX INC | 15,000 | reported | 03 Sept 2025 | tx 8+477,176 |
| Foamix Pharmaceuticals Ltd. | 0 | reported | 09 Mar 2020 | tx 12+224,651−270,086 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 03 Sept 2025 | GRANT_AWARD | ORTHODONTIX INC | 7,500 | — | |
| 03 Sept 2025 | GRANT_AWARD | ORTHODONTIX INC | 15,000 | 0.00 USD | deriv |
| 10 Jun 2025 | PURCHASE | ORTHODONTIX INC | 129,000 | 1.60 USD | first after silence |
| 29 Sept 2023 | GRANT_AWARD | ORTHODONTIX INC | 61,676 | 0.00 USD | deriv |
| 03 Jan 2023 | PURCHASE | ORTHODONTIX INC | 110,000 | 1.42 USD | first after silence |
| 07 Sept 2022 | GRANT_AWARD | ORTHODONTIX INC | 50,000 | 0.00 USD | deriv |
| 07 Apr 2020 | PURCHASE | ORTHODONTIX INC | 64,000 | 2.43 USD | first after silence |
| 09 Mar 2020 | OTHER | Foamix Pharmaceuticals Ltd. | 112,200 | — | |
| 09 Mar 2020 | OTHER | Foamix Pharmaceuticals Ltd. | 24,000 | — | deriv |
| 09 Mar 2020 | OTHER | Foamix Pharmaceuticals Ltd. | 21,435 | — | deriv |
| 09 Mar 2020 | OTHER | Foamix Pharmaceuticals Ltd. | 38,156 | — | deriv |
| 09 Mar 2020 | OTHER | Foamix Pharmaceuticals Ltd. | 49,412 | — | deriv |
| 09 Mar 2020 | OTHER | Foamix Pharmaceuticals Ltd. | 24,883 | — | deriv |
| 27 Feb 2020 | GRANT_AWARD | Foamix Pharmaceuticals Ltd. | 38,156 | 0.00 USD | deriv |
| 20 Jan 2020 | GRANT_AWARD | ORTHODONTIX INC | 40,000 | 0.00 USD | deriv |
| 16 May 2019 | GRANT_AWARD | Foamix Pharmaceuticals Ltd. | 49,412 | 0.00 USD | deriv |
| 26 Nov 2018 | PURCHASE | Foamix Pharmaceuticals Ltd. | 50,000 | 3.89 USD | |
| 27 Nov 2018 | PURCHASE | Foamix Pharmaceuticals Ltd. | 50,000 | 3.92 USD | |
| 28 Nov 2018 | PURCHASE | Foamix Pharmaceuticals Ltd. | 12,200 | 3.88 USD | |
| 08 May 2018 | GRANT_AWARD | Foamix Pharmaceuticals Ltd. | 24,883 | 0.00 USD | deriv |
3 purchases reported after at least 12 months of silence — most recent on 10 Jun 2025.